Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

How to Prepare Project Report on Pharmaceutical Processing Industry?

Drug manufacturing companies work under strict laws and regulations. Their processes need to comply with relevant drugs act in their respective countries.

Therefore, if you are planning to invest in pharmaceutical processing, a good project report will be necessary. Besides the prominent aspects of a project report, you should pay close attention to the following issues in a pharmaceutical processing report.

1. Marketing

This industry is very competitive. I need not stress the value of detailed market analysis. You need to understand the status of market competition and the demand for pharmaceutical products. A proper market analysis will additionally help you prepare an excellent pharmaceutical business plan. Given your market analysis report, you will develop a marketing plan.

2. Government approval

In almost all countries, there are laws and regulations for the manufacture, distribution, and administration of drugs. Consider giving a status report on these requirements when making the final project status report.

3. Manufacturing Process

It would help if you had a picture of the process you will employ in making your drugs. Outline the quality checks and balances in the process. State the required pharmaceutical intermediates and their corresponding active pharmaceutical ingredients.

4. Machines and Equipment

You need to identify the equipment you will need, such as homogenizers, spectrophotometer, tabulating machines, etc. to ensure the machines meet quality specifications. You may also need to put down a plan to train workers on their operations.

How Does the Drug Manufacturing Process Work?

If you are an aspiring drug manufacturer, you should know how the bulk drug manufacturing process works. This is a complicated process and requires professional skills in molecular biology, medical microbiology, and pharmacy.

The process involves four steps, namely:

  • Milling
  • Granulation
  • Coating
  • Tabulation

Milling is important because it makes the drug powder uniform. It ensures uniform distribution of the active pharmaceutical ingredients. Additionally, milling makes it easier to formulate the drug into a syrup or emulsion.

After milling, you can use wet or dry granulation to form granules. You then coat them and compress the drugs using a tabulating machine. Alternatively, you can fill the granules into capsules.

For any chemical industry business ideas, prioritize the security of your staff. Ensure workers have sufficient PPEs. Have plans to protect them from chemical poisoning. Install eyewashes and emergency showers in both production units and laboratories.

Pre-Feasibility Report on Bulk Drug Manufacturing Process

Before you set up a feasibility report or start making a business plan, you first need to do a pre-feasibility study. It is the conclusions of this study that will make you decide whether to proceed to the project feasibility report or not.

Implementing a pharmacy business plan is an expensive affair. Please do not put any investment into a business plan of this magnitude without looking at its feasibility study report.

Considering the variety of pharmaceutical products, a feasibility plan will help you decide on the most relevant product for your target market. The results of pre-feasibility and feasibility studies will inform your marketing strategy plan. At the pre-feasibility stage, you get to review the technical skills required for the bulk drug manufacturing process. You also assess the knowledge level and determine whether you have the knowledge and skills.

Lastly, this report looks at the financial demands of a chemical project report on bulk drug processing. From here, you will decide on the feasibility of the project.

How to Grow Pharmaceutical Intermediates Market?

The pharmaceutical industry relies on pharmaceutical intermediates. We use these chemicals to produce active pharmaceutical ingredients (API). 

To grow the pharmaceutical intermediates market, therefore, we should focus on the drug manufacturing industry. Here are some tips on how we can grow this industry.

1. Investment in Research and Development

We should encourage governments and established drug manufacturers to invest in research and development of new medicines. New drug development will increase the need for pharmaceutical intermediates. Consequently, this will cause the growth of the industry.

2. Boost Generic Drug Manufacturing

Feasibility study reports for project ideas in pharmaceuticals show a growing demand for generics. This demand is particularly high in developing countries. More investment in generic drugs will result in increased demand for pharmaceutical intermediates.

3. Collaborations

It is quite expensive to run a pharmaceutical intermediate processing company. If you look at a project summary example for the local industry and you will notice the huge investment. One way of cushioning the industry is to encourage collaborations, mergers, and acquisitions. Working together gives small-scale companies a competitive advantage. It lowers their operation costs and improves revenue.

How to Set Up a Chemical Industry Business Plan?

Writing a chemical industry business plan begins with a pre-feasibility study. Here, you look at the various business ideas in chemical manufacturing. You then evaluate each of these ideas based on:

1. Skills and Knowledge

If you are interested in the chemical manufacturing industry, I assume that you have some skills or knowledge in this sector. If so, look at the skills required for each idea you have. Which of these ideas marches your skills and knowledge?

2. Financial Resources

Different chemical processes have different cost implications. Try to review each idea against the expected financial input. You can examine some business plan examples on the internet to get a hint on required inputs. Once you have a convincing pre-feasibility report, you can proceed to make a feasibility report meaning the idea is profitable and viable.

The next step in setting up a chemical industry business plan is to prepare a small business marketing plan. The results of your feasibility report will help do this.

Chemical manufacturing is not only expensive, but it is also strictly regulated by law. It would be best if you had an innovative marketing strategy to break even. It would be best if you did an accurate market analysis.

A project report on the pharmaceutical industry helps you assess the dynamics of the industry. You will want to know who the major chemical manufacturers are. You will also assess the availability of raw materials and machinery for your pharmaceutical industry.

In your project report, you will also address the technical aspects of the pharmaceutical manufacturing process. You need to draw a flow diagram for the process. Lastly, sit down and draw a business plan for your chemical industry business. You will need the information from all the above processes. Additionally, a business plan will consider the financial implications of your pharmaceutical industry project report.


We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 8 of 26 | Total 259 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 25 26   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

MANNITOL - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Mannitol is a polyol (sugar alcohol) widely used in the food and pharmaceutical industries because of its unique functional properties. Mannitol is the generic name for a Food and Drug Administration (FDA) approved drug used as an osmotic diuretic and a mild renal vasodilator. Mannitol is typically administered intravenously, but can also be taken orally, depending on the purpose. Intravenously, it is used to treat excessive intracranial pressure, oliguria, and to expand openings in the blood-brain barrier. Orally, mannitol is used a sweetening agent in confections for people with diabetes and, in higher concentrations, as a laxative for children. It is also used as an anti-caking & free flow agent. Mannitol is non-cariogenic and has a low caloric content. Mannitol occurs as an odorless, sweet-tasting, white, crystalline powder with a melting range of 165° - 168° and a pKa of 3.4. One gram is sol¬uble in about 5.5 ml of water (at 25°) and it is very slightly soluble in alcohol. It is an isomer of sorbitol and is typically produced today by the hydrogenation of specialty glucose syrups. Mannitol is commercially available in variety of powder and granular forms. Mannitol is used as the dust that coats chewing gum, where it keeps the gum from absorbing moisture and getting sticky. This is due to its humectant (moisture trapping) properties, and very low hydroscopicity (does not attract moisture from the air). Mannitol is mostly produced in parallel to the sorbitol production and in fact, it is a co-product along with sorbitol. While sorbitol production is followed from starch, mannitol can be produced using sugar as base material. Commercially, D-Mannitol is obtained by the reduction of invert sugar. Mannitol is not presently produced in the country. It is imported from outside. The demand growth rate is around 7 to 8% per annum. The present Indian demand was around 2100 tonnes per annum for the last year. Currently, there are over a dozen units engaged in manufacture of intravenous fluids in the country with combined capacity of more than 1000 million bottles per annum. The Indian demand for IV fluids is around 500 million bottles per annum. Coming to global demand it is around 60000 tonnes per annum. The demand for mannitol is likely to go up steadily in the coming years, in view of the expected growth of the healthcare. As there is no production of mannitol at present in India, there is an ample space for new entrepreneurs to venture into this sector.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

QUININE SULPHATE FROM CINCHONA BARK - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Quinine sulfate belongs to the anti-malarial category of drugs and it is the sulfate of an alkaloid obtained from the bark of species of Cinchona. The bark of cinchona produces several alkaloids. The most important alkaloid, quinine, has certain febrifuge properties. Of 38 species of cinchona, four species have economic value for the production of quinine: C. calisaya, C. legeriana, C. officianalis and C. succirubra. It contains not less than 99 percent and not more than 101 percent of total alkaloid salt, calculated as (C20H24N2O2)2•H2SO4, on the anhydrous basis. Cinchona trees remain the only practical source of quinine. Cinchona is a genus of tropical evergreen trees and shrubs, belonging to the family Rubiaceae. Not all species of cinchona can be used to produce quinine. Quinine is the chief alkaloid of cinchona bark (known as 'Fever Bark'), a tree found in South America. It is a natural white crystalline alkaloid having antipyretic (fever-reducing), antimalarial, analgesic (painkilling), anti-inflammatory properties and a bitter taste. It is a stereoisomer of quinidine which, unlike quinine, is an anti-arrhythmic. Quinine contains two major fused-ring systems: the aromatic quinoline and the bicyclic quinuclidine. In 1820, Pelletier and Caventou isolated quinine and cinchonine from cinchona. Though it has been synthesized in the lab, the bark of the cinchona tree is the only known natural source of quinine. Even today, quinine is obtained entirely from the natural sources due to the difficulties in synthesizing the complex molecule. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. The growth has been driven by many factors, such as legislative reforms, growth in contract manufacturing and outsourcing, value added foreign acquisitions and joint ventures and India's acu-men and expertise in reverse engineering of patented drug molecules. India has, in the meantime, been trying to comply with the World Trade Organization's Trade Related Intellectual Property Agreement (TRIPs) obligations. There is a very good scope for new entrepreneurs in this sector.
Plant capacity: 60 MT/AnnumPlant & machinery: 497 Lakhs
Working capital: -T.C.I: Cost of Project : 747 Lakhs
Return: 45.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

GLYCERIN - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Glycerin is a simple polyol compound. It is a colorless, odorless, viscous liquid that is widely used in pharmaceutical formulations. Glycerol has three hydrophilic hydroxyl groups that are responsible for its solubility in water and its hygroscopic nature. The glycerol backbone is central to all lipids known as triglycerides. Glycerol is sweet-tasting and of low toxicity. Glycerin is a 3 carbon polyol. It is an inevitable constituent of all animal and vegetable oils and fats. It is a product with many applications in pharmaceuticals and cosmetics. It is also a chemical intermediary in adhesives, tensio-actives and explosives. It is extracted chemically from castor oil before cracking. Glycerin is also a by-product in soap and oleochemical production, using natural fats and oils as raw materials or as a by-product in biodiesel production, during transesterification of vegetable oils into methyl esters. It is a clear, water-white, viscous, sweet tasting hygroscopic liquid. Crude glycerine is an essential by-product obtained from the manufacture of soaps, fatty acids, fatty alcohols and fatty acids methyl esters. After refining, glycerine will be used in many applications which cover pharmaceutical, cosmetics/toiletries, resins, cellulose films, paper, polyols, tobacco, food and drink, esters, nitration and other chemical uses and applications. Glycerin is an important raw material used in the manufacture of synthetic resins, namely alkyd resins and explosives. It is also used in the manufacture of lubricants, drugs, plasticizers, etc. In foods and beverages, glycerol serves as a humectant, solvent and sweetener, and may help preserve foods. It is also used as filler in commercially prepared low-fat foods and as a thickening agent in liqueurs. Glycerol is also used to manufacture mono- and di-glycerides for use as emulsifiers, as well as polyglycerol esters going into shortenings and margarine. The market for glycerine in domestic and international market is good. Some of the highest quality glycerin produced in the world is supplied by Malaysia and Indonesia. Glycerine competes in the market with other products such as sorbitol, glycols and many polyols from petrochemical feedstocks. If glycerine prices drop dramatically, also these products will be confronted with the unfair competitive situation created by the reduction in excise duties. Price of glycerin has increased in recent times,largely due to increase in vegetable oil prices. The forecast growth for glcerine is around 2.2% per year, driven mainly by personal care and food products. Good solubility, taste and lower pricing give glycerin an edge on sorbitol in toothpastes and mouth washes. Glycerin is used in food products either directly or as one of its derivatives, such as glycerol mono-stearate. The demand for glycerin in the food sector is growing as a result of the continuing trend toward lowering the fat content in foods. There is a very good scope for this product and new entrepreneurs should venture into this field.
Plant capacity: ---Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

7 AMINOCEPHALOSPORANIC ACID (7 ACA) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

7 ACA or 7 Aminocephalosporanic acid is made from Cephalosporin C and is a key intermediate for synthesizing cephalosporin antibiotics, the B lactam antibiotics family. 7 ACA is a starting compound for the production of various semi-synthetic cephalosporins of different generations. These compounds are made by modification of the side chains at positions 3 and 7 of 7-aminocephalosporanic acid (7 ACA). It is used to produce many cepholosporins pharmaceutical bulks, such as cefazolin sodium, cefotaxime sodium, ceftriaxone sodium, cefoperazone sodium, ceftazime sodium, cefuroxime sodium and so on. Originally, the commercial processes were based on solvent extraction. 7 Aminocephalosporanic acid (7 ACA), until recently it has been produced by chemical deacylation of the natural antibiotic cephalosporin C. The disadvantage of this method is multiple steps, low yield, use of various organic solvents and treatment of a lot of toxic waste. Alternatively, 7 ACA can be produced by a simpler and more environmentally sound process using a bio-catalytic method based on DAAO and glutaryl hydrolase for enzymatic deacylation of CPC to 7 ACA. However, few enzymes capable of this direct deacylation have been discovered, probably because of the unusual nature of the D aminoadipyl side chain of cephalosporin C. Enzyme engineering is a fast growing application in the pharmaceutical market. Cephalosporin is defined as any of a group of broad-spectrum derived from species of fungi of the genus Cephalosporium and is related to the penicillins in both structure and mode of action but relatively penicillinase resistant antibiotics. These antibiotics have low toxicity for the host, considering their broad antibacterial spectrum. They have the active nucleus of beta lactam ring which results in a variety of antibacterial and pharmacologic characteristics when modified mainly by substitution at 3 and 7 positions. Their antibacterial activities result from the inhibition of mucopeptide synthesis in the cell wall. They are widely used to treat gonorrhea, meningitis, pneumococcal, staphylococcal and streptococcal infections. The cephalosporin class of antibiotics is usually divided into generations by their antimicrobial properties. Three generations of cephalosporins are recognized and the fourth has been grouped. Each newer generation of cephalosporins has broader range of activity against gram-negative organisms but a narrower range of activity against gram positive organisms than the preceding generation. The newer agents have much longer half-lives resulting in the decrease of dosing frequency. Accordingly, the third-generation cephalosporins can penetrate into tissues well, and thus antibiotic levels are good in various body fluids. The cephalosporins belong to the family of ? lactam antibiotics. These are named after the reactive moiety of the compounds, the ? lactam ring. In CPC, the four membered ? lactam ring is coupled to a six membered dihydrothiazine ring to form the nucleus, 7 aminocephalosporanic acid (7 ACA), and a side chain, ? aminoadipic acid, is coupled via an amide bond to the nucleus. The total world market for cephalosporins was estimated to be approximately 10 billion US$ in 2000, and ? lactam antibiotics in general accounting for over 65% of the world antibiotic market. According to IMS Health, cephalosporins as single preparation and in combination preparations are ranked 10 in the global drug sales in 2003 by an estimated sales of 8.3 billion US$, the highest ranking for any of the anti infectives classes. The size of the Indian pharmaceutical industry is poised to treble over the decade. It is expected to grow from about USD 6.3 billion in 2005 to about USD 20 billion by 2015, registering a CAGR of 12.3% and outperforming the global average of 9% in 2009 to 10. In terms of scale, the Indian pharmaceutical market is the 14th largest in the world but will graduate to the top 10 by 2015, overtaking Brazil, Mexico, South Korea and Turkey. India’s growth to a USD 20 billion market by 2015 indicates that the incremental growth of USD 14 billion over the coming decade is likely to be the third highest in the world. Demand for 7 ACA is principally determined by the market sales scale of downstream products. In terms of developing trend, ceftriaxone and cefazolin were two mainstream products of 7 ACA. Therefore, the market change in these two products directly affected the change in production-sales relations of 7 ACA. After dosage conversion, according to estimate the use of 7 ACA for making certriaxone accounted for 47.7% of the total consumption of 7 ACA. Obviously, ceftriaxone had become the biggest consumer of cephalosporins raw materials of 7 ACA series, followed by cefazolin. Not only ceftriaxone boosted morale, but cefotaxime, cefazolin sodium, cefoperazone sodium, cefoperazone sulbactam, ceftazidime, cefuroxime, etc were also the direct contributors of the family. At present, major players in the market include Shijiazhuang Pharmaceutical Group Co. Ltd., Fujian Fukang Pharmaceutical Group Co. Ltd., Shanxi Weiqida Pharmaceutical Group Co. Ltd. and Zhuhai United Labs Co. Ltd. At present there is no production of 7 ACA in the country and the demand is met by imports. There is a good scope for capacity creation in India. New entrepreneurs should venture into this sector.
Plant capacity: 150 MT/AnnumPlant & machinery: 1486 Lakhs
Working capital: -T.C.I: Cost of Project : 2167 Lakhs
Return: 64.00%Break even: 42.00%
Add to Inquiry Add to Inquiry Basket

MAIZE & ITS BY-PRODUCTS - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Maize is one of the main cereal grains which is produced throughout India and is placed 3rd position in agricultural base production though it is not our staple basic food. Maize is constituted by hull, germ, protein, starch and moisture. Maize is generally processed using the dry and wet milling processes. There is dry and wet milling process for manufacturing of by products such as starch, zein, germ and hulls. Starch is used in the manufacture of number of products such as starch esters, starch phosphates, glucose, dextrose, sorbitol, ethyl alcohol etc. Starch is the basic constituent of maize and it is converted to liquid glucose by adopting series of digestion steps on starch. It will be basically enzyme and acid digestion system. It may be enzyme - enzyme system or only acid digestion system. In the production of liquid glucose there is some production of dextrose anhydride. India is the fifth largest producer of maize in the world contributing 3% of the global production. In India, maize is grown in all seasons i.e., kharif, Rabi and summer. Of these three seasons, nearly 90% of the production is from kharif season, 7 to 8% during Rabi season and remaining 1 to 2% during summer season. Since the maize is rain dependent, it is mainly grown during kharif season. Presently, in India, maize is mainly used for preparation of poultry feed and extraction of starch. Out of total arrivals to the mandis nearly 75% of the produce is bought by the poultry feed manufacturers and 20% is purchased by the starch extractors. The wet milling industry in India is limited to certain pockets such as Gujarat, Maharashtra, Madhya Pradesh, Punjab, Karnataka and Chhattisgarh. There are about 17 wet milling units with a crushing capacity of about 3400 MT of maize/day. Gujarat is the largest producer of starch, having six units with a total crushing capacity of 1350 MT of maize per day, followed by Maharashtra with 5 units and capacity of 1050 MT and Madhya Pradesh with 3 units and capacity of 450 MT maize. There is a good scope to venture into this field for new entrepreneurs. Few Indian Major Players are as under: Anil Products Ltd. Anil Starch Products Ltd. Bharat Starch Inds. Ltd. English Indian Clays Ltd. Gayatri Bioorganics Ltd. Gujarat Ambuja Exports Ltd. Gujarat Ambuja Proteins Ltd. Gulshan Polyols Ltd. Indian Maize & Chemicals Ltd. International Bestfoods Ltd. K G Gluco Biols Ltd. Kamala Sugar Mills Ltd. Karnataka State Agro Corn Products Ltd. Laxmi Starch Ltd. Origin Agrostar Ltd. Pondicherry Agro Service & Inds. Corpn. Ltd. Rai Agro Inds. Ltd. Riddhi Siddhi Gluco Biols Ltd. Santosh Starch Ltd. Santosh Starch Products Ltd. Sayaji Industries Ltd. Sukhjit Starch & Chemicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Universal Starch-Chem Allied Ltd. Wockhardt Health Care Ltd. Cost Estimation: Capacity : 5250 MT/Annum Starch 1125 MT/Annum Liquid Glucose 4500 MT/Annum Dextrose Monohydrous 562 MT/Annum Oxidised Starch 900 MT/Annum Hull 1800 MT/Annum Zien 1050 MT/Annum Germ as by Products
Plant capacity: -Plant & machinery: 179 Lakhs
Working capital: -T.C.I: Cost of Project : 543 Lakhs
Return: 43.00%Break even: 59.00%
Add to Inquiry Add to Inquiry Basket

PHARMACEUTICAL GRADE SUGAR - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Pharmaceutical grade sugar can be manufactured by using cane beet or sugar cane itself. This is the more pure form of sugar may not contain sulphur and heavy toxic material like lead arsenic and mercury etc. This is used mainly in preparation of pharmaceutical and food products. There are few companies in organized sector manufacturing pharmaceutical grade sugar. Dhampur is one of the leading manufacturers. There is good domestic as well as export market for the pharma grade sugar. It can be concluded that there is a very good scope for new entrepreneurs if they produce the product with European competitive price.
Plant capacity: 15000 MT/AnnumPlant & machinery: 293 Lakhs
Working capital: -T.C.I: Cost of Project : 613 Lakhs
Return: 45.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Gelatin Sponge - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economic

Gelatin sponge is a sterile compressed sponge has haemostatic properties and in precisely used for controlling bleeding. By virtue of its versatile usage for haemostatic function in dental treatment, in gaining eminence and being a innovative product, its demand is increasing day by day. In view of the horizons of its field of application, the future scope of this product is also bright. To cope up with the increasing demand of gelatin sponge, the imperative need of the hour is to set up more number of units for its manufacture. Thus, in the limelight of the facts enumerated above, a new entrepreneur can venture into this field. It is a lucrative project with bright scope.
Plant capacity: 6000000 Nos./AnnumPlant & machinery: 91 Lakhs
Working capital: -T.C.I: Cost of Project : 269 Lakhs
Return: 46.00%Break even: 49.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet, Syrup & Injectables) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunity

The Indian pharmaceutical industry today is in the front rank of India’s science based industry with wide ranging capabilities in the complex field of drugs manufacture and technology. The Indian pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the share. It is an extremely fragmented market with severe price competition and govt. price control. The pharmaceutical industry, with its rich scientific talents and research capabilities, supported by intellectual property protection regime is well set to take on the international market. The demand of pharmaceutical products are increasing very fast. So, any new entrepreneur can venture in to this field. Few Indian Major Players are as under: A C E Laboratories Ltd. A Tosh & Sons (India) Ltd. Abbott India Ltd. Adinath Bio-Labs Ltd. Advik Laboratories Ltd. Agio Pharmaceuticals Ltd. Alchem International Ltd. Alchemist Ltd. Alembic Ltd. Alintosch Pharmaceuticals Ltd. Alkem Laboratories Ltd. Alps Hospital Pvt. Ltd. Alved Pharma & Foods Pvt. Ltd. Ambalal Sarabhai Enterprises Ltd. American Remedies Ltd. Amol Pharmaceuticals Pvt. Ltd. Andre Laboratories Ltd. Anil Bioplus Ltd. Anil Starch Products Ltd. Ankur Drugs & Pharma Ltd. Apex Laboratories Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B A & Brothers (Eastern) Ltd. Bengal Chemicals & Pharmaceuticals Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Bio-Ethicals Pharma Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Bliss G V S Pharma Ltd. Brabourne Enterprises Ltd. Brawn Biotech Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caldern Pharmaceuticals Ltd. Casil Industries Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cipla Ltd. Concept Pharmaceuticals Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Croslands Research Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dolphin Laboratories Ltd. Dorcas Market Makers Ltd. Duchem Laboratories Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Endo Labs Ltd. Esskay Pharmaceuticals Ltd. Eupharma Laboratories Ltd. F D C Ltd. Fem Care Pharma Ltd. Flamingo Pharmaceuticals Ltd. Franco-Indian Pharmaceuticals Pvt. Ltd. Fredun Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. [Merged] Glaxosmithkline Pharmaceuticals Ltd. Glenmark Generics Ltd. Glenmark Pharmaceuticals Ltd. Global Spin-Weave Ltd. Gufic Biosciences Ltd. H & B Stores Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Bio-Pharmaceutical Corpn. Ltd. Harshita Ltd. Hindustan Antibiotics Ltd. Icpa Health Products Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. John Wyeth (India) Ltd. Jubilant Life Sciences Ltd. Kamala Sugar Mills Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kopran Ltd. Larite Industries Ltd. Lawacoated Papers Pvt Ltd. Lekar Pharma Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka Labs Ltd. M J Pharmaceuticals Ltd. Magnet Labs Pvt. Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Mankind Pharma Ltd. Matrix Laboratories Ltd. Max Healthcare Institute Ltd. Mayo (India) Ltd. Medispan Ltd. Meher Pharma (India) Ltd. Merck Ltd. Micro Labs Ltd. Midas Pharmasec Ltd. Millennium Laboratories Ltd. Nadukkara Agro Processing Co. Ltd. Neelkanth Technologies Ltd. Neon Laboratories Ltd. Norris Medicines Ltd. Omega Laboratories Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Ortin Laboratories Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panjon Ltd. Parbhudas Kishordas Tobacco Products Pvt. Ltd. Parenteral Drugs (India) Ltd. Parle Bisleri Pvt. Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfizer Ltd. Phar-East Laboratories Ltd. Pharmed Ltd. Plethico Pharmaceuticals Ltd. Psychotropics India Ltd. Pure Health Products Pvt. Ltd. Pure Pharma Ltd. R P G Life Sciences Ltd. Radicura & Co. Ltd. Rajat Pharmachem Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Rekvina Laboratories Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rusan Pharma Ltd. S O L Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarthi Pharmaceuticals Ltd. Sayaji Industries Ltd. Sekhsaria Chemicals Ltd. Silver Oak (India) Ltd. Smith Stanistreet Pharmaceuticals Ltd. Solvay Pharma India Ltd. Standard Pharmaceuticals Ltd. State Trading Corpn. Of India Ltd. Stellar Exports Ltd. Strides Arcolab Ltd. Strides Specialties Pvt. Ltd. Surya Pharmaceutical Ltd. Suyash Laboratories Ltd. Themis Medicare Ltd. Torrent Pharmaceuticals Ltd. Trans Medicare Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unimed Investments Ltd. Unique Sugars Ltd. United Breweries (Holdings) Ltd. Vellanova Pharmaceuticals Ltd. Venus Remedies Ltd. Vera Pharma Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wanbury Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. Win Laboratories Pvt. Ltd. Winmac Laboratories Ltd. Wockhardt Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Pharmacy Ltd. Zenotech Laboratories Pvt. Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd. Cost Estimation: Capacity : 9000000 Nos./Annum (Bruphen Tablets) 900000 Bottles/Annum (Paracetamol Syrup) 1200000 Bottles/Annum (Dextrose Saline) 1800000 Nos./Annum (Streptomycine Injection)
Plant capacity: -Plant & machinery: 85 Lakhs
Working capital: -T.C.I: Cost of Project : 350 Lakhs
Return: 42.00%Break even: 56.00%
Add to Inquiry Add to Inquiry Basket

Glycerine - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Glycerine is known as glycerol. Glycerol combined with fatty acids in the form of easters known as the glycerides is universally distributed and functions in the development and reproduction of all plant and animal life. Glycerol plays an important part as an intermediary product in the metabolism of the living organism but seldom remains in the free state in natural products. It is generally agreed that in plants glycerol and the glycerides originate from carbohydrates produced by photosynthesis from carbon dioxide and water. Glycerine was first discovered in 1779 by Scheele who heated a mixture of litharage and olive oil and extracted it with water. Glycerine is used in nearly every industry. Glycerine has wide applications in drugs and pharmaceuticals, cosmetics, in food products, in tobacco etc. Besides these, glycerine is also used as lubricant and used in manufacture of alkyd resins and explosives. It also used in textile industry and in tooth paste. Glycerine is used in cream and lotion based cosmetic to keep the skin soft and moisture. Glycerine is a greasy, so it also used in lip-stick, chip-stick, lip gloves etc. It is used in flavouring and coloring food products. It is generally obtained as a byproduct from manufacture of soaps and fatty acids. Glycerine enjoys very wide use in various industries because of its chemical and physical properties. Glycerin competes in the market with other products such as sorbitol, glycols and many polyols from petrochemical feedstocks. If and when there would be drop in price of glycerin due to over supply scenario, perhaps glycerin would become competitive with other products such as sorbitol and may be able to penetrate the market for sorbitol and polyols. It has good domestic and export demand, so there is a very good scope in this sector and new entrepreneurs should venture into this field. Few Indian Major Players are as under: Adi Finechem Ltd. Foods, Fats & Fertilisers Ltd. Godrej Consumer Products Ltd. Godrej Industries Ltd. Golden Agro Tech Inds. Ltd. Gujarat Godrej Innovative Chemicals Ltd. [Erstwhile] Hindustan Unilever Ltd. Ind Barath Commodities Ltd. Jocil Ltd. Micron Chemicals Ltd. Nirma Ltd. Organic Chemoils Ltd. Ritesh International Ltd. Southern Online Bio Technologies Ltd. Sree Rayalaseema Alkalies & Allied Chemicals Ltd. Sudha Agro Oil & Chemical Inds. Ltd. Tata Oil Mills Co. Ltd. [Merged] Wipro Ltd.
Plant capacity: 1 Ton/DayPlant & machinery: 51 Lakhs
Working capital: -T.C.I: 174 Lakhs
Return: 40.00%Break even: 43.00%
Add to Inquiry Add to Inquiry Basket

Maize Starch & Liquid Glucose - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Starch is a group of polysaccharides, composed of glucopyranose units joined together by glucosidric linkages. It conforms to the molecular formula. Where a varies from a few hundred to over one million. Starch is found as the reserve carbohydrate in various parts of plants and is enzymetically broken down to glucose to other carbohydrates according to the metabolic needs of the plants. Starch has many industrial applications. These include (a) Textile Industry (b) Food Industry (c) Paper Industry (d) Pharmaceutical Industry (e) Manufacture of modified starch. Liquid Glucose produced in India is consumed by the confectionery industry. It is used also in textile printing and in biscuit and canning industries, tanning and tobacco curing. This is used in leather, textile, pharmaceutical and other industries. The history of starch industry dates back to early forties. There are few units at present in the country producing starch from maize and three units producing starch from Tapioca in the organized sector. There is bright market potential for maize starch and liquid glucose. New entrepreneurs can venture into this field. Few Indian Major Players are as under: Anil Products Ltd. Anil Starch Products Ltd. [Merged] Bharat Starch Inds. Ltd. [Merged] English Indian Clays Ltd. Gayatri Bioorganics Ltd. Gujarat Ambuja Exports Ltd. Gujarat Ambuja Proteins Ltd. [Merged] Gulshan Polyols Ltd. Indian Maize & Chemicals Ltd. International Bestfoods Ltd. [Merged] K G Gluco Biols Ltd. [Merged] Kamala Sugar Mills Ltd. Karnataka State Agro Corn Products Ltd. Laxmi Starch Ltd. Origin Agrostar Ltd. Pondicherry Agro Service & Inds. Corpn. Ltd. Rai Agro Inds. Ltd. Riddhi Siddhi Gluco Biols Ltd. Santosh Starch Ltd. Santosh Starch Products Ltd. Sayaji Industries Ltd. Sukhjit Starch & Chemicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Universal Starch-Chem Allied Ltd. Wockhardt Health Care Ltd. [Merged] Cost Estimation: Capacity : Maize Starch 22312 MT/Annum Liquid Glucose 8925 MT/Annum Germ (Bye Product) 1785 MT/Annum Fibre (Bye Product) 892 MT/Annum Steep Water (Bye Product) 2677 MT/Annum
Plant capacity: -Plant & machinery: 1477 Lakhs
Working capital: -T.C.I: Cost of Project : 2425 Lakhs
Return: 41.00%Break even: 44.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 8 of 26 | Total 259 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 25 26   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top